Cite
HARVARD Citation
Meade, L. et al. (2019). The Effect of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors in Patients Prescribed Regular U-500 Insulin. Annals of pharmacotherapy. 53 (11), pp. 1111-1116. [Online].